Nikolaos Alexiou
Overview
Explore the profile of Nikolaos Alexiou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
55
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rapti V, Poulakou G, Mousouli A, Kakasis A, Pagoni S, Pechlivanidou E, et al.
Antibiotics (Basel)
. 2024 Sep;
13(9).
PMID: 39334987
Antimicrobial resistance poses a major threat to human health worldwide and the implementation of antimicrobial stewardship programs (ASPs), including antimicrobial de-escalation (ADE), is a multifaceted tool for minimizing unnecessary or...
2.
Angelopoulou V, Pouliakis A, Alexiou N, Ioannidi P, Vagiona D, Ekmektzoglou K, et al.
Children (Basel)
. 2023 Jun;
10(6).
PMID: 37371178
Background: Magnetic Resonance Imaging (MRI) is a valuable diagnostic tool but often requires sedation to complete, especially in children. Dexmedetomidine (DEX) is an a2 agonist, for which there are experimental...
3.
Giannitsioti E, Pefanis A, Gogos C, Lekkou A, Dalekos G, Gatselis N, et al.
Int J Infect Dis
. 2021 Mar;
106:213-220.
PMID: 33711517
Objective: The clinical profile, management and outcome of infective endocarditis (IE) may be influenced by socioeconomic issues. Methods: A nationwide prospective study evaluated IE during the era of deep economic...
4.
Kyriazopoulou E, Liaskou-Antoniou L, Adamis G, Panagaki A, Melachroinopoulos N, Drakou E, et al.
Am J Respir Crit Care Med
. 2020 Aug;
203(2):202-210.
PMID: 32757963
Although early antimicrobial discontinuation guided by procalcitonin (PCT) has shown decreased antibiotic consumption in lower respiratory tract infections, the outcomes in long-term sepsis sequelae remain unclear. To investigate if PCT...
5.
Kyriazopoulou E, Sinapidis D, Halvatzis S, Velissaris D, Alexiou N, Kosmas V, et al.
Int J Antimicrob Agents
. 2019 Nov;
55(1):105836.
PMID: 31704213
Although analysis of retrospective studies has documented survival benefit from the addition of a macrolide to the treatment regimen for community-acquired pneumonia (CAP), no data are available to determine if...